A Controlled Trial of Losartan in Posttraumatic Stress Disorder (LOSe-PTSD)

Clinical Trial ID NCT02709018

Rank	Title	Journal	Year	PubWeight™‹?›
1	The renin-angiotensin pathway in posttraumatic stress disorder: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms.	J Clin Psychiatry	2012	1.54
2	Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.	Psychoneuroendocrinology	2010	1.24
3	Blood-borne angiotensin II acts in the brain to influence behavioral and endocrine responses to psychogenic stress.	J Neurosci	2011	0.95
4	Angiotensin type 1 receptor inhibition enhances the extinction of fear memory.	Biol Psychiatry	2013	0.89
5	Anxiolytic-like effect of losartan injected into amygdala of the acutely stressed rats.	Pharmacol Rep	2012	0.82
6	An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms.	Am J Med Genet B Neuropsychiatr Genet	2015	0.80
7	Angiotensin type 1a receptors on corticotropin-releasing factor neurons contribute to the expression of conditioned fear.	Genes Brain Behav	2015	0.79